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journal homepage: www.j-bgm.comABSTRACTAssociation of transforming growth factor-b1
gene T869C polymorphisms with osteopenia
and osteoporosis in TaiwaneseTai-Feng Hsu a,d, Yu-Ting Yang b,d, Pei-Fen Wu c, San-Ho Hung b,
Kwok-Wan Yang ba Personalized Medical Service Center, Division of Laboratory Medicine, Fooyin University Hospital,
Pingtung, Taiwan
b Department of Radiology, Fooyin University Hospital, Pingtung, Taiwan
c Department of Laboratory Medicine, Fooyin University Hospital, Pingtung, TaiwanBackground: Osteoporosis is a multifactorial disease with a strong genetic component characterized by reduced bone mass
density (BMD) and increased risk of fragility fractures. On the other hand, genetic determinants are also modulated by
hormonal, environmental and nutritional factors. Many studies had found that the genetic polymorphisms in certain sus-
ceptibility genes would cause the pathogenesis of osteoporosis. Growth factors and cytokines which participate in the
regulation of bone resorption and bone formation seems to be potential risk factors. Transforming growth factor beta
1(TGF-b1) T869C polymorphisms has been reported that plays an important role in bone formation, and its effect on bone
remodeling makes TGF-b1 gene a candidate for mediating the genetic influence on BMD and risk of fracture.
Materials and Methods: In this study, we investigated the association between osteopenia/osteoporosis and TGF-b1 gene
polymorphisms in 77 Taiwanese people (21 osteoporotic patients and 56 healthy controls). Genomic DNA sample was iso-
lated from peripheral bloods and then analyzed by the techniques of polymerase chain reaction- restriction fragment length
polymorphism (PCR-RFLP). Genotype and allele frequencies were calculated and analyzed using the Chi-square test.
Results: In the control group, the distribution of TT genotype (14.3%) was about one half times than those in osteoporotic
groups (9.5%). The higher frequencies of CC (42.9%) and TC (47.6%) genotypes in the osteoporotic patients indicated that C
allele (90.5%) may correlate with BMD and disease formation. However, there was no statistically difference between the
distribution of TGF-b1 genotypes or allele frequencies (p>0.05) in the osteoporotic groups.
Discussion: Since the patient number we collected were not large enough for statistical analysis of TGF-b1 polymorphism,
more samples are needed for further investigation. We hope this study can provide the evidence to develop an early
screening test for patients who have genetic risk factor of osteoporosis, preventing them from such disease.d Contributed equally.
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